Survivin expression is regulated by coexpression of human epidermal growth factor receptor 2 and epidermal growth factor receptor via phosphatidylinositol 3-kinase/AKT signaling pathway in breast cancer cells.
about
ErbB receptors: from oncogenes to targeted cancer therapiesSurvivin and Tumorigenesis: Molecular Mechanisms and Therapeutic StrategiesRon knockdown and Ron monoclonal antibody IMC-RON8 sensitize pancreatic cancer to histone deacetylase inhibitors (HDACi)Functional Characterization of D9, a Novel Deazaneplanocin A (DZNep) Analog, in Targeting Acute Myeloid Leukemia (AML)ErbB/HER receptor activation and preclinical efficacy of lapatinib in vestibular schwannoma.Monoclonal antibody against the ectodomain of E-cadherin (DECMA-1) suppresses breast carcinogenesis: involvement of the HER/PI3K/Akt/mTOR and IAP pathwaysFoxM1B regulates NEDD4-1 expression, leading to cellular transformation and full malignant phenotype in immortalized human astrocytesTrastuzumab Sensitizes Ovarian Cancer Cells to EGFR-targeted Therapeutics.Expression of HER-2 affects patient survival and paclitaxel sensitivity in endometrial cancerYM155 induces EGFR suppression in pancreatic cancer cells.Current status of anti-human epidermal growth factor receptor 2 therapies: predicting and overcoming herceptin resistanceFoxM1 is a downstream target and marker of HER2 overexpression in breast cancerImmune effects of trastuzumabCross-talk between epidermal growth factor receptor and hypoxia-inducible factor-1alpha signal pathways increases resistance to apoptosis by up-regulating survivin gene expression.Discovery of novel second mitochondria-derived activator of caspase mimetics as selective inhibitor of apoptosis protein inhibitors.Pro-oncogene Pokemon promotes breast cancer progression by upregulating survivin expressionTherapeutic approaches for HER2-positive brain metastases: circumventing the blood-brain barrier.Iron-free and iron-saturated bovine lactoferrin inhibit survivin expression and differentially modulate apoptosis in breast cancer.The role of survivin in diagnosis, prognosis and treatment of breast cancer.Soluble-E-cadherin activates HER and IAP family members in HER2+ and TNBC human breast cancers.Survivin expression in tuberous sclerosis complex cells.The kinesin Eg5 inhibitor K858 induces apoptosis but also survivin-related chemoresistance in breast cancer cells.Survivin upregulation, dependent on leptin-EGFR-Notch1 axis, is essential for leptin-induced migration of breast carcinoma cells.Delivery of chemo-sensitizing siRNAs to HER2+-breast cancer cells using RNA aptamers.Basal Protein Expression Is Associated With Worse Outcome and Trastuzamab Resistance in HER2+ Invasive Breast Cancer.The twisted survivin connection to angiogenesisPI-3K/Akt pathway-dependent cyclin D1 expression is responsible for arsenite-induced human keratinocyte transformation.Disabling the mitotic spindle and tumor growth by targeting a cavity-induced allosteric site of survivinSurvivin is an independent predictor of short-term survival in poor prognostic breast cancer patients.YM-155 potentiates the effect of ABT-737 in malignant human glioma cells via survivin and Mcl-1 downregulation in an EGFR-dependent context.Transcriptional and post-transcriptional controls of survivin in cancer cells: novel approaches for cancer treatment.Multifaceted targeting in cancer: the recent cell death players meet the usual oncogene suspects.MEK1/2 inhibition enhances the radiosensitivity of cancer cells by downregulating survival and growth signals mediated by EGFR ligands.Survivin inhibitor YM-155 sensitizes tumor necrosis factor- related apoptosis-inducing ligand-resistant glioma cells to apoptosis through Mcl-1 downregulation and by engaging the mitochondrial death pathwayCYP1A1 regulates breast cancer proliferation and survival.Comparative study on the immunogenicity between an HLA-A24-restricted cytotoxic T-cell epitope derived from survivin and that from its splice variant survivin-2B in oral cancer patients.Effect of lapatinib on the development of estrogen receptor-negative mammary tumors in mice.Mitotic deregulation by survivin in ErbB2-overexpressing breast cancer cells contributes to Taxol resistance.Targeting inhibitor of apoptosis proteins in combination with ErbB antagonists in breast cancer.Survivin regulation by HER2 through NF-κB and c-myc in irradiated breast cancer cells.
P2860
Q24683709-595014BA-6014-46A0-B585-D37FB3EFB150Q26766250-5607DEA0-9B4B-4C3E-9758-37D66A8EECA3Q28534954-F318B45D-A09C-453C-851B-8932D5140A3DQ28546856-AB8F2126-3A04-408D-BE1C-3AE88DEB9305Q30474678-8689E00B-F7C2-48EF-ADE4-50C43E108785Q33584432-2F2899F5-803E-4D56-8A23-5C2FEA12BD03Q33767150-AD3D11CE-DD94-420B-B208-EDF52AE7068FQ33816185-89649B58-DF27-468E-9D0D-70C57D2DB9D9Q34253654-FFEFF2C9-AA8F-4CA9-BA73-E69FF8E30454Q34313903-FC7763D5-166D-4DC0-BAF1-F6F47651EA50Q34355748-56D4F12D-7481-4D0F-A308-0625C39D33B1Q34725700-279CB5DC-821A-4127-BD0A-107DAF44F136Q35057976-2AB910F8-F018-4C93-8D6D-39EF87B071D6Q35094456-34964270-AA63-40E5-BD43-C52C9CD6E73AQ35119355-B3723D96-CAA6-42D4-97C3-AAC773478B57Q35558942-52026EF1-38F5-44C3-8136-B5E9B7037573Q35608531-B57A6A84-BBFE-4059-A53B-FF344B118B77Q35633919-B09DC3BC-2640-4B4B-BB97-B1CBB4D2D6EEQ35667653-9BDCC24B-1013-47D9-9B80-2B4169E3986BQ35770840-3379B8DC-7A79-44B1-B2B9-E39569F33615Q35844066-43DC39F5-806E-4569-8AF2-0ACC065BD0F2Q35963684-805E0349-1BBB-411B-94D6-B1C4F4E1976AQ35992790-2E991822-B8AF-4E56-9D17-8E8A36572FEAQ36107033-7D1362FB-6B7A-4A3A-A32E-AC81EE917343Q36279794-7061E108-B070-46CA-A4B0-34C6B11DCF76Q36301932-752D02DB-0EB8-42DA-A274-A889628818BDQ36381304-6EB221FD-348F-4BD5-B2FC-44B3064AEC1AQ36603591-123488B1-34B0-4981-BEB3-680E7A7F2B83Q36609883-3FBC4F61-7F7C-4443-A5B8-CF0A7CEA2702Q36681060-9BCA8E5F-D33E-4F27-B1B6-DB64B6395C9EQ36682871-EA4ABF9E-A5E8-4728-9C2B-A572060E1244Q36804432-7E450AE2-2C68-4B1F-B32E-70C6F3727AA1Q36976683-7D835FDA-6E86-47EE-80E9-FE027BBD95DEQ37027010-24297F36-C2AB-4CC0-A4E9-C5E3BE75E59AQ37039023-A00E3731-E6DF-489F-88AE-2CDC132A47B9Q37064709-D51E0CC6-DA35-4369-8F13-6B32C023D8B1Q37090804-1782E1E7-8FDD-4358-994A-6FE92C9ED805Q37146751-0A87B4CB-05EA-4F01-AF38-6B880201A08BQ37277197-1EB671AF-C212-42BB-A759-4030206D99DCQ37295467-AC8AA058-B2B8-4E8D-BD4B-717465EB12F4
P2860
Survivin expression is regulated by coexpression of human epidermal growth factor receptor 2 and epidermal growth factor receptor via phosphatidylinositol 3-kinase/AKT signaling pathway in breast cancer cells.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Survivin expression is regulat ...... athway in breast cancer cells.
@en
type
label
Survivin expression is regulat ...... athway in breast cancer cells.
@en
prefLabel
Survivin expression is regulat ...... athway in breast cancer cells.
@en
P2093
P1433
P1476
Survivin expression is regulat ...... athway in breast cancer cells.
@en
P2093
Hiroko Asanuma
Kenjiro Kamiguchi
Koichi Hirata
Masaaki Sato
Noriyuki Sato
Toshihiko Torigoe
Tousei Ohmura
Yoshihiko Hirohashi
P304
11018-11025
P356
10.1158/0008-5472.CAN-05-0491
P407
P577
2005-12-01T00:00:00Z